Guglielmo Roma
Novartis
107 Papers
289 Citations
Guglielmo Roma is an academic researcher from Novartis. The author has contributed to research in topics: Biology & Gene. The author has an hindex of 31, co-authored 99 publications. Previous affiliations of Guglielmo Roma include University of Naples Federico II & Queen Mary University of London.
Chat about Author
Papers
A single-cell atlas of the airway epithelium reveals the CFTR-rich pulmonary ionocyte
Lindsey W. Plasschaert,Rapolas Žilionis,Rapolas Žilionis,Rayman Choo-Wing,Virginia Savova,Judith Knehr,Guglielmo Roma,Allon M. Klein,Aron B. Jaffe +8 more
TL;DR: Single-cell RNA sequencing analysis is used to identify cell types in the tracheal epithelium, including previously unidentified ionocytes, which express high levels of the cystic fibrosis transmembrane conductance regulator, CFTR.
The genome of melon (Cucumis melo L.)
Jordi Garcia-Mas,Andrej Benjak,Walter Sanseverino,Michael Bourgeois,Gisela Mir,Víctor M. González,Elizabeth Henaff,Francisco Câmara,Luca Cozzuto,Ernesto Lowy,Tyler Alioto,Salvador Capella-Gutierrez,José Blanca,Joaquín Cañizares,Pello Ziarsolo,Daniel Gonzalez-Ibeas,Luis Rodriguez-Moreno,Marcus Droege,Lei Du,Miguel Álvarez-Tejado,Belen Lorente-Galdos,Marta Melé,Marta Melé,Luming Yang,Yiqun Weng,Arcadi Navarro,Tomas Marques-Bonet,Miguel A. Aranda,Fernando Nuez,Belén Picó,Toni Gabaldón,Guglielmo Roma,Roderic Guigó,Josep M. Casacuberta,Pere Arús,Pere Puigdomènech +35 more
TL;DR: The data suggest that transposon amplification may in part explain the increased size of the melon genome compared with the close relative cucumber, and a low number of nucleotide-binding site–leucine-rich repeat disease resistance genes were annotated, suggesting the existence of specific defense mechanisms in this species.
744
Self-organization and symmetry breaking in intestinal organoid development
Denise Serra,Denise Serra,Urs Mayr,Urs Mayr,Andrea Boni,Andrea Boni,Ilya Lukonin,Ilya Lukonin,Markus Rempfler,Ludivine Challet Meylan,Michael B. Stadler,Michael B. Stadler,Petr Strnad,Petr Strnad,Panagiotis Papasaikas,Panagiotis Papasaikas,Dario Vischi,Annick Waldt,Guglielmo Roma,Prisca Liberali,Prisca Liberali +20 more
TL;DR: These findings reveal how single cells exposed to a uniform growth-promoting environment have the intrinsic ability to generate emergent, self-organized behaviour that results in the formation of complex multicellular asymmetric structures.
Cell Types of the Human Retina and Its Organoids at Single-Cell Resolution.
Cameron S. Cowan,Magdalena Renner,Magdalena Renner,Martina De Gennaro,Brigitte Gross-Scherf,David Goldblum,Yanyan Hou,Martin Munz,Tiago M. Rodrigues,Jacek Krol,Tamas Szikra,Rachel Cuttat,Annick Waldt,Panagiotis Papasaikas,Panagiotis Papasaikas,Roland Diggelmann,Claudia P. Patino-Alvarez,Patricia Galliker,Stefan E. Spirig,Dinko Pavlinic,Nadine Gerber-Hollbach,Sven Schuierer,Aldin Srdanovic,Márton Balogh,Riccardo Panero,Akos Kusnyerik,Arnold Szabo,Michael B. Stadler,Michael B. Stadler,Selim Orgül,Simone Picelli,Pascal W. Hasler,Andreas Hierlemann,Hendrik P. N. Scholl,Hendrik P. N. Scholl,Guglielmo Roma,Florian Nigsch,Botond Roska,Botond Roska +38 more
TL;DR: This resource identifies cellular targets for studying disease mechanisms in organoids and for targeted repair in human retinas and implicate unexpected cell types in diseases such as macular degeneration.
477
SMN2 splice modulators enhance U1-pre-mRNA association and rescue SMA mice
James Palacino,Susanne E. Swalley,Cheng Song,Atwood K. Cheung,Lei Shu,Xiaolu Zhang,Mailin Van Hoosear,Youngah Shin,Donovan N. Chin,Caroline Gubser Keller,Martin Beibel,Nicole A. Renaud,Thomas M. Smith,Michael Salcius,Xiaoying Shi,Marc Hild,Rebecca Servais,Monish Jain,Lin Deng,Caroline Bullock,Michael McLellan,Sven Schuierer,Leo Murphy,Marcel J. J. Blommers,Cecile Blaustein,Frada Berenshteyn,Arnaud Lacoste,Jason R. Thomas,Guglielmo Roma,Gregory A. Michaud,Brian Tseng,Jeffery A. Porter,Vic E. Myer,John A. Tallarico,Lawrence G. Hamann,Daniel Curtis,Mark C. Fishman,William F. Dietrich,Natalie Dales,Rajeev Sivasankaran +39 more
TL;DR: A potent, orally active, small-molecule enhancer of SMN2 splicing that elevates full-length SMN protein and extends survival in a severe SMA mouse model is described, demonstrating the feasibility of small molecule-mediated, sequence-selective splice modulation and the potential for leveraging this strategy in other splicing diseases.
401